# Editas Medicine, Inc.: Form 8-K, filed May 14, 2021

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2021-05-14
- Accepted by EDGAR: May 14, 2021, 16:57 ET
- Period: 2021-05-14
- Accession: 0001104659-21-066941
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000110465921066941/tm2116240d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000110465921066941/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000110465921066941/tm2116240d1_8k.htm

Filed May 14, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-066941. Last ingested by Listed: Nov 10, 2026, 02:10 ET. No prices; not investment advice.